Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Free Realtime Quote SEK

C-Rad AB (publ) (CRAD-B.ST)

30.50
+0.50
+(1.67%)
As of 12:07:48 PM GMT+2. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
469,000
469,000
424,600
301,326
261,152
Cost of Revenue
146,000
146,000
137,400
96,024
90,923
Gross Profit
323,000
323,000
287,200
205,302
170,229
Operating Expense
253,000
253,000
243,000
183,545
133,664
Operating Income
70,000
70,000
44,200
21,757
36,565
Net Non Operating Interest Income Expense
9,700
9,700
-300
-272
-256
Pretax Income
79,800
79,800
43,900
21,486
35,739
Tax Provision
23,300
23,300
8,400
14,006
10,637
Net Income Common Stockholders
56,500
56,500
35,500
7,479
25,102
Diluted NI Available to Com Stockholders
56,500
56,500
35,500
7,479
25,102
Basic EPS
1.71
1.67
1.05
0.22
0.74
Diluted EPS
1.71
1.67
1.05
0.22
0.74
Basic Average Shares
33,825.33
33,832.34
33,809.52
33,764.01
33,738.91
Diluted Average Shares
33,825.33
33,832.34
33,809.52
33,764.01
33,933.90
Total Operating Income as Reported
70,000
70,000
44,200
21,758
35,995
Total Expenses
399,000
399,000
380,400
279,569
224,587
Net Income from Continuing & Discontinued Operation
56,500
56,500
35,500
7,479
25,102
Normalized Income
56,500
56,500
35,500
7,479
25,102
Interest Income
--
--
61
162
10
Interest Expense
--
--
371
416
169
Net Interest Income
9,700
9,700
-300
-272
-256
EBIT
70,000
70,000
44,200
21,902
35,908
EBITDA
79,900
79,900
53,100
32,014
45,615
Reconciled Cost of Revenue
146,000
146,000
137,400
96,024
90,923
Reconciled Depreciation
9,900
9,900
8,900
10,112
9,707
Net Income from Continuing Operation Net Minority Interest
56,500
56,500
35,500
7,479
25,102
Total Unusual Items Excluding Goodwill
--
--
233
--
--
Total Unusual Items
--
--
233
--
--
Normalized EBITDA
79,900
79,900
53,100
32,014
45,615
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 7/23/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MEDI.OL Medistim ASA
164.00
+1.55%
 
MODU.HE Modulight Oyj
1.3320
-0.89%
 
XVIVO.ST Xvivo Perfusion AB (publ)
307.20
+2.40%
 
GETI-B.ST Getinge AB (publ)
186.25
+0.89%
 
BICO.ST BICO Group AB (publ)
37.26
-5.48%
 
EKTA-B.ST Elekta AB (publ)
49.16
-2.07%
 
VITR.ST Vitrolife AB (publ)
147.80
-0.14%
 
ARAY Accuray Incorporated
1.6100
+1.90%
 
EW Edwards Lifesciences Corporation
75.54
-0.66%
 
INMD InMode Ltd.
14.26
-12.08%